8ZD

N-{2-[({1-[(2R)-pentan-2-yl]piperidin-4-yl}{[3-(trifluoromethyl)phenyl]carbamoyl}amino)methyl]phenyl}propanamide

Created:	2017-03-22
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where 8ZD is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	74
Chiral Atom Count	1
Bond Count	76
Aromatic Bond Count	12

2D diagram of 8ZD

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-{2-[({1-[(2R)-pentan-2-yl]piperidin-4-yl}{[3-(trifluoromethyl)phenyl]carbamoyl}amino)methyl]phenyl}propanamide
Systematic Name (OpenEye OEToolkits)	~{N}-[2-[[[1-[(2~{R})-pentan-2-yl]piperidin-4-yl]-[[3-(trifluoromethyl)phenyl]carbamoyl]amino]methyl]phenyl]propanamide
Formula	C₂₈ H₃₇ F₃ N₄ O₂
Molecular Weight	518.614
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	FC(F)(F)c1cccc(c1)NC(=O)N(C2CCN(CC2)C(CCC)C)Cc3ccccc3NC(CC)=O
SMILES	CACTVS	3.385	CCC[CH](C)N1CCC(CC1)N(Cc2ccccc2NC(=O)CC)C(=O)Nc3cccc(c3)C(F)(F)F
SMILES	OpenEye OEToolkits	2.0.6	CCCC(C)N1CCC(CC1)N(Cc2ccccc2NC(=O)CC)C(=O)Nc3cccc(c3)C(F)(F)F
Canonical SMILES	CACTVS	3.385	CCC[C@@H](C)N1CCC(CC1)N(Cc2ccccc2NC(=O)CC)C(=O)Nc3cccc(c3)C(F)(F)F
Canonical SMILES	OpenEye OEToolkits	2.0.6	CCC[C@@H](C)N1CCC(CC1)N(Cc2ccccc2NC(=O)CC)C(=O)Nc3cccc(c3)C(F)(F)F
InChI	InChI	1.03	InChI=1S/C28H37F3N4O2/c1-4-9-20(3)34-16-14-24(15-17-34)35(19-21-10-6-7-13-25(21)33-26(36)5-2)27(37)32-23-12-8-11-22(18-23)28(29,30)31/h6-8,10-13,18,20,24H,4-5,9,14-17,19H2,1-3H3,(H,32,37)(H,33,36)/t20-/m1/s1
InChIKey	InChI	1.03	UHTIDTWXNLTVFU-HXUWFJFHSA-N

Related Resource References

Resource Name	Reference
PubChem	137348772

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.